urate-lowering therapy

Bajpai, R., Partington, R., Muller, S., Forrester, H., Mallen, C. D., Clarson, L., et al. (2024). Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keae229
Russell, M. D., Roddy, E., Rutherford, A. I., Ellis, B., Norton, S., Douiri, A., et al. (2022). Treat-to-target urate-lowering therapy and hospitalisations for gout: results from a nationwide cohort study in England. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keac638